Top Markets
#1 Black Phoenix Black Phoenix +2,485.28%
#2 Nesa Nesa +743.87%
#3 Ontology Gas Ontology Gas +141.61%
#4 ADO Protocol ADO Protocol +103.71%
#5 Cortex Cortex +95.45%
#6 Kinesis Silver Kinesis Silver +54.43%
#7 Magma Finance Magma Finance +34.30%
#8 Pons Pons +33.70%
#9 OpenEden OpenEden +33.50%
#10 Non-Playable Coin Non-Playable Coin +32.03%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
GRAIL Inc. GRAIL Inc.

GRAIL Inc.

GRAL
Clasificación en acciones #4687
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Precio por acción
$79.40
Capitalización bursátil
$3.41B
Cambio (1 día)
-3.80%
Cambio (1 año)
133.05%
País
US
Comercio GRAIL Inc. (GRAL)

Categoría

Healthcare
Ganancias de GRAIL Inc. (GRAL)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di GRAIL Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de GRAIL Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH